Back to Therapeutic Nuclear Medicine
Radionuclide Therapy
Neuroendocrine Tumor Therapies
Peptide receptor radionuclide therapy (PRRT) for well-differentiated neuroendocrine tumors expressing somatostatin receptors.
Available Therapies
Lu-177 DOTATATE / DOTATOC Therapy (PRRT)
Used for treatment of well-differentiated neuroendocrine tumors expressing somatostatin receptors.
Y-90 DOTATOC Therapy
Used in selected cases of advanced neuroendocrine tumors.
Need a PET-CT Scan, Nuclear Medicine Investigation or Targeted Therapy?
Detect Earlier. Stage Accurately. Treat Better.
Book Your Appointment Today